- By Alex David
- Sun, 21 Sep 2025 01:42 AM (IST)
- Source:JND
Scientists at Stanford University and the Arc Institute have shown for the first time that artificial intelligence can be used to design “therapeutic” proteins from scratch. In a study published in Cell earlier this month, scientists in Benjamin King’s lab showed they could use machine learning to create enzybiotics, targeting specific bacteria.”These are bacteriophages – viruses that infect and destroy bacteria. The development demonstrates how generative A.I. can help produce powerful, functional lab-tested viruses that have the potential to instead open up new avenues for medicine and biotechnology. But as much hope as the accomplishment brings for addressing antibiotic resistance, it also presents pressing ethical, safety and biosecurity concerns.
From Code to Contagion
Scientists enlisted phiX174, a small bacteriophage that infects E. coli bacteria, for this research project. With Evo - their artificial intelligence genome model developed by scientists - as their guide, they generated 302 new viral blueprints that hadn't previously existed in nature.
After lab synthesis and testing:
-16 AI-created designs produced working viruses
- These phages successfully infected and destroyed E. coli
- Under electron microscopes, they appeared indistinguishable from natural viruses
This marks the first time AI has created functional viruses capable of replication.
ALSO READ: Samsung Galaxy Z Fold 6 To Be Available At Rs 54,000 Less During Amazon Great Indian Festival 2025
Why It Matters: Phages as the Next Antibiotics
The achievement could overhaul phage therapy, a burgeoning alternative to antibiotics in combating drug-resistant bacteria. Taken in contrast to broad-spectrum antibiotics, bacteriophages are very precise: they only seek out and destroy certain strains of bacteria and preserve healthy microbes.
AI could make phage therapy scalable by:
- Designing tailored phages for stubborn infections
- Rapidly building genetic libraries for targeted treatments
- Accelerating discovery far beyond traditional methods
In short, this is directed evolution—not waiting for nature to provide solutions but instructing AI to invent them.
Beyond Medicine: Rewriting Biology’s Playbook
The implications go deeper than healthcare:
- AI-assisted viral design may reveal new genetic rules
- Each failed or successful phage sharpens our understanding of life’s constraints
- Biology and computation are converging, blurring the line between discovery and invention
Just as AI is being used to design proteins and materials, it’s now shaping the genetic code of life itself.
Risks and Red Flags
Not everyone is celebrating. Critics warn of potential misuse:
- The same tools could, in theory, design harmful human-infecting viruses
- AI-generated phages might behave unpredictably in complex ecosystems
- Rapid viral evolution could create unforeseen outcomes
Biosecurity specialists insist that strict supervision and safety precautions are also needed as AI grows in influence in the world of genetic design.
ALSO READ: Qualcomm Snapdragon Secures 40% Share in India’s Premium Smartphone Market
A Glimpse Into Biology’s Future
So far, the experiments have been limited to lab studies on bacteria. Scaling this to complicated viruses — or using it safely in human beings — remains a daunting challenge. Still, the resulting 16 viable viruses from AI blueprints marks a clear turning point.
Artificial intelligence, in short, is no longer just analyzing biology; it is making it. As the word confronts antibiotic resistance, AI-designed phages could be part of the solution. But a higher-stakes coda is emerging, in which society must reckon with the more profound question: what happens when machines can invent life?
Final Thoughts: AI-designed phages could change medicine by combatting antibiotic resistance; however, their power requires strong ethical and security safeguards for ethical deployment. The future of synthetic biology depends not only on what AI can create – but how wisely we use it.